OverviewSuggest Edit

Affinergy is a company developing site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces in order to kickstart biology toward an intended outcome. It is focused on developing coatings and medical devices for the orthopedic and cardiovascular markets.

Latest Updates

Employees (est.) (Oct 2019)22(+5%)

Key People/Management at Affinergy

Peyton Anderson

Peyton Anderson

MBA Chief Executive Officer
Jonathan Gindes

Jonathan Gindes

MBA, RAC Chief Financial Officer and Senior Vice-President of Business Development
Daniel Kenan

Daniel Kenan

M.D., Ph.D. Scientific Co-Founder
Mark Grinstaff

Mark Grinstaff

Ph.D. Scientific Co-Founder
Show more

Affinergy Financials and Metrics

Summary Metrics

Founding Date


Affinergy total Funding

$4.6 m

Affinergy latest funding size

$3 m

Time since last funding

14 years ago

Affinergy investors

Affinergy's latest funding round in March 2006 was reported to be $3 m. In total, Affinergy has raised $4.6 m
Show all financial metrics

Affinergy Online and Social Media Presence

Embed Graph

Affinergy Frequently Asked Questions

  • When was Affinergy founded?

    Affinergy was founded in 2003.

  • Who are Affinergy key executives?

    Affinergy's key executives are Peyton Anderson, Jonathan Gindes and Daniel Kenan.

  • How many employees does Affinergy have?

    Affinergy has 22 employees.

  • Who are Affinergy competitors?

    Competitors of Affinergy include GraphWear Technologies, Repro Med Systems and Pulse Biosciences.